FDA Approves Personalized Tx for Metastatic Bladder Cancer
Balversa indicated for treatment of bladder cancer with FGFR3 or FGFR2 genetic alteration
Read MoreFor latest News and updates
Posted by Physicians Weekly | Apr 12, 2019 | HealthDay |
Balversa indicated for treatment of bladder cancer with FGFR3 or FGFR2 genetic alteration
Read MorePosted by Physicians Weekly | Mar 21, 2019 | HealthDay |
In teens and women younger than 50, absent iron stores and anemia more common in blood donors
Read MorePosted by Physicians Weekly | Jan 3, 2019 | HealthDay |
Risk for proximal cancers low among patients without broad-definition anemia and/or abdominal mass
Read More(Reuters) – British drugmaker AstraZeneca on Thursday said its ovarian cancer and anemia...
Read MorePosted by Physicians Weekly | Dec 6, 2018 | HealthDay |
Wilbur Lam and Rob Mannino. Photo: Christopher Moore App uses color and metadata from fingernails to detect hemoglobin levels in the blood
Read More